Back to search

Effects of (±) 3,4-methylene–dioxymethamphetamine (ecstasy) on dopamine system function in humans

Data up to Jan 2025

Published2002
Citations39
References48

Total Citations Per Year

Abstract

References (48)

A RATING SCALE FOR DEPRESSION

1960 • 30,921 citations

A Systematic Method for Clinical Description and Classification of Personality Variants

1987 • 3,661 citations

An inventory for assessing different kinds of hostility.

1957 • 2,604 citations

Neurogenetic Adaptive Mechanisms in Alcoholism

1987 • 2,300 citations

The Reward Deficiency Syndrome: A Biogenetic Model for the Diagnosis and Treatment of Impulsive, Addictive and Compulsive Behaviors

2000 • 929 citations

Positron emission tomographic evidence of toxic effect of MDMA (“Ecstasy”) on brain serotonin neurons in human beings

1998 • 673 citations

Serotonin Neurotoxicity after (±)3,4-Methylenedioxymethamphetamine (MDMA; “Ecstasy”): A Controlled Study in Humans

1994 • 336 citations

5-HT Modulation of Dopamine Release in Basal Ganglia in Psilocybin-Induced Psychosis in Man—A PET Study with [11C]raclopride

1999 • 277 citations

THE EFFECTS OF METHYLENEDIOXYMETHAMPHETAMINE (MDMA, “ECSTASY”) ON MONOAMINERGIC NEUROTRANSMISSION IN THE CENTRAL NERVOUS SYSTEM

1996 • 185 citations

Localization of MDMA‐induced brain activity in healthy volunteers using low resolution brain electromagnetic tomography (LORETA)

2001 • 177 citations

Carrier‐dependent and Ca2+‐dependent 5‐HT and dopamine release induced by (+)‐amphetamine, 3,4‐methylendioxy‐methamphetamine, p‐chloroamphetamine and (+)‐fenfluramine

1997 • 175 citations

Striatal dopamine transporter density in major depression

1999 • 173 citations

MDMA induced dopamine release in vivo: role of endogenous serotonin

1997 • 166 citations

MDMA Elicits Behavioral and Neurochemical Sensitization in Rats

1998 • 159 citations

Long-lasting effects of (±)3,4-methylene-dioxymethamphetamine (Ecstasy) on serotonin system function in humans

2000 • 143 citations

The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3, 4-methylenedioxymethamphetamine (‘Ecstasy’) in healthy volunteers

2000 • 135 citations

Personality disorder in obsessive-compulsive volunteers, well comparison subjects, and their first-degree relatives

1993 • 125 citations

Striatal serotonin is depleted in brain of a human MDMA (Ecstasy) user

2000 • 120 citations

Neuroendocrine correlates of temperamental traits in humans

2000 • 116 citations

Psychopathological Correlates of Reduced Dopamine Receptor Sensitivity in Depression, Schizophrenia, and Opiate and Alcohol Dependence12

2001 • 100 citations

Effects of MDMA (Ecstasy) on Prepulse Inhibition and Habituation of Startle in Humans after Pretreatment with Citalopram, Haloperidol, or Ketanserin

2001 • 99 citations

Altered neuroendocrine and behavioral responses to m -chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users

1999 • 86 citations

Effect of 3,4-Methylenedioxymethamphetamine (MDMA) on Hippocampal Dopamine and Serotonin

1998 • 72 citations

Further neuroendocrine evidence for reduced D2 dopamine receptor function in alcoholism

1993 • 62 citations

Changes in serotonin, dopamine and noradrenaline levels in striatum and nucleus accumbens after repeated administration of the abused drug MDMA in rats

2001 • 61 citations

MDMA (‘ecstasy’) enhances basal acetylcholine release in brain slices of the rat striatum

2000 • 54 citations

Blunted growth hormone response is associated with early relapse in alcohol-dependent patients.

1995 • 54 citations

Differential toxic effects of methamphetamine (METH) and methylenedioxymethamphetamine (MDMA) in multidrug-resistant (mdr1a) knockout mice

1997 • 52 citations

CGS 10746B, a Novel Dopamine Release Inhibitor, Blocks the Establishment of Cocaine and MDMA Conditioned Place Preferences

1998 • 52 citations

Central dopaminergic function in Anorexia and Bulimia Nervosa: a psychoneuroendocrine approach

2001 • 51 citations

Differential regulation of dopamine D2 and D3 receptors by chronic drug treatments.

2000 • 51 citations

Reduced dopaminergic function in alcoholics is related to severe dependence

1996 • 45 citations

Dopamine function in obsessive—compulsive disorder: Growth hormone response to apomorphine stimulation

1997 • 44 citations

Involvement of Brain Catecholamines and Acetylcholine in Growth Hormone Hypersecretory States

1995 • 41 citations

Abnormal structure of human striatal dopamine re-uptake sites in habitually violent alcoholic offenders: a fractal analysis

1998 • 41 citations

Alcohol dependence, family history, and D2 dopamine receptor function as neuroendocrinologically assessed with apomorphine

1995 • 37 citations

Antisociality, substance dependence, and theDRD5 gene: A preliminary study

2000 • 34 citations

Homovanillic Acid and Dopamine-β-hydroxylase in Male Youth: Relationships with Paternal Substance Abuse and Antisocial Behavior

1995 • 31 citations

Growth hormone and prolactin response to bromocriptine in patients with Huntington's chorea.

1978 • 29 citations

Aggressive Behaviour and Hostility in Depression: Clinical Aspects

1993 • 27 citations

Neuroendocrine responses to levodopa in multiple system atrophy (MSA)

1999 • 24 citations

Repeated exposure to methylenedioxymethamphetamine (MDMA) alters nucleus accumbens neuronal responses to dopamine and serotonin

1998 • 22 citations

Hypothalamo-pituitary function and dopamine dependence in untreated parkinsonian patients

1991 • 17 citations

Recurrent Mood Disorders

1993 • 16 citations

Evidence for Reduced Dopamine D2 Receptor Sensitivity in Postwithdrawal Alcoholics

1995 • 15 citations

Bromocriptine: Effect on Serum Prolactin and Growth Hormone in Psychogeriatric Hospital Patients

1978 • 3 citations

Effect of bromocriptine on insulin, growth hormone and prolactin responses to arginine in obesity

1996 • 3 citations

Dopaminergic Regulation of Prolactin Secretion in the Hyperprolactinemic Syndrome

1983 • 1 citations

Cited By (0)

Loading...